EU competition authorities to rule on Novo’s purchase of Catalent by 6 December
EU competition authorities will decide by 6 December whether to approve Novo Holdings’ acquisition of contract drugmaker Catalent, the European Commission said in a document published on its website on Monday.
BELIEBTE BEITRÄGE
State financing of nature protection measures at COP-16
November 5, 2024
Spain deploys 7,500 troops to flood zone
November 5, 2024
Indonesia is expected to have a normal rainy season in 2025
November 5, 2024
LIVEÜBERTRAGUNG